Hepatocyte growth factor/scatter factor (HGF/SF) can stimulate growth of gastrointestinal epithelial cells in vitro;
H epatocyte growth factor/scatter factor (HGF/ SF) was first identified as a highly potent hepatocyte mitogen (Gohda et al, 1988; Nakamura et al, 1989) but is now known as a multifunctional cytokine based on its ability to stimulate proliferation, movement, and/or morphogenesis of a broad spectrum of cultured epithelial cells expressing the tyrosine kinase receptor encoded by the c-met proto-oncogene (Gherardi and Stoker, 1991; Montesano et al, 1991; Rosen et al, 1994; Rubin et al, 1991; Vande Woude, 1992; Zarnegar and Michalopoulos, 1995) . HGF/SF is produced in cells of mesenchymal origin, whereas c-met is expressed in adult and embryonic epithelium, implicating HGF/SF-Met signal transduction pathways as important in the epithelial-mesenchymal interaction that occurs during embryogenesis, tissue organization, and organogenesis. Gene targeting studies have shown that HGF/SF-Met signaling is required for the normal development of liver, skeletal muscle, and placenta Schmidt et al, 1995; Uehara et al, 1995) .
In the fetal digestive tract, c-met transcripts were found in the epithelia of the intestinal anlagen and the villi, whereas the distribution of HGF/SF RNA showed dynamic changes during mouse development by in situ hybridization (Sonnenberg et al, 1993) . Immunohistochemical analysis of temporal expression revealed that both HGF/SF and c-Met could be detected between 7 and 8 weeks of gestation in human fetal digestive tissues (Kermorgant et al, 1997) . These results suggest that HGF/SF-Met signaling participates in digestive system morphogenesis. Moreover, previous studies demonstrated that HGF/SF can stimulate both esophageal and gastrointestinal epithelial growth in primary cultures (Fukamachi et al, 1994; Takahashi et al, 1995) . HGF/SF was also shown to enhance both intestinal mucosal repair and function in vivo (Kato et al, 1997a (Kato et al, , 1997b Nishimura et al, 1998) . Furthermore, it was shown recently that HGF/SF stimulated gastrointestinal tyrosine kinase activity, which colocalizes with c-Met in the brush border membrane of enterocytes (Sunitha et al, 1999) . Taken together, results from these studies indicate that paracrine HGF/SF stimulation may play an important role in digestive tissue development and regeneration.
Recently, we described some of the consequences of inappropriate expression of HGF/SF using transgenic mice in which expression of a mouse HGF/SF cDNA was regulated by the mouse metallothionein (MT) gene promoter and 5'/3' genomic flanking sequences as a model system. HGF/SF transgenic mice exhibited ectopic skeletal muscle and melanocytes in the central nervous system, suggesting that HGF/SF can function as a true morphogenetic factor in vivo by regulating differentiation and/or migration of select populations of myoblasts and neural crest cells, respectively, during embryogenesis . These mice also demonstrated enhanced hepatic growth (Sakata et al, 1996) , renal failure (Takayama et al, 1997a) , and the development of diverse histological types of tumors of both epithelial and mesenchymal origin (Otsuka et al, 1998; Takayama et al, 1997b) . In this report, we describe morphologic and functional alterations appearing in the digestive tract of HGF/SF transgenic mice, and we also discuss the possible involvement of these findings in inflammatory bowel disease (IBD).
Results

High Incidence of Premature Death Caused by Intestinal Pseudo-Obstruction in HGF/SF Transgenic Mice
Nine MT-HGF/SF founder mice were generated in which the transgene broadly expressed a characteristic 2.4kb RNA transcript . Based on the level of transgene expression, we chose two lines, MH19 and MH37, as representatives for detailed analysis. In both lines, expression of the MT-HGF/SF transgene was high throughout the entire digestive tract and markedly induced after treatment with drinking water containing zinc (Fig. 1A) . Endogenous c-met expression was comparable between transgenic and control colons (Fig. 1B) . Transgenic mice were normal at birth but frequently experienced premature mortality. In this study, we found that 33 of 67 (49%) MH19 and 10 of 20 (50%) MH37 mice, mostly females, died by 6 months of age (Table 1) . Pregnant females were particularly susceptible to an early demise, virtually all (10 of 11) succumbing during or shortly after pregnancy. Of the total premature deaths, 20 of the 33 MH19 (61%) and 8 of the 10 MH37 (80%) mice died between 8 and 15 weeks with highly distended abdomens and progressive wasting syndrome. Dissection of these moribund transgenic mice revealed distension of the gastrointestinal tract (Fig. 2C) , in which the position of the transitional zone between the distended and narrow segments of the intestine varied from animal to animal. In some transgenic mice, the entire colon appeared narrow. In others, only the most distal part of the rectum was narrow, resulting in distension of the entire intestine. The narrow segment rarely spanned from the distal small intestine to the distal rectum. This phenotype is often associated with an intestinal obstruction; however, no overt mechanical obstruction was found at any site along the gastrointestinal tract. We conclude that the majority of premature deaths in these HGF/SF transgenic mice was caused by sporadic intestinal obstruction of unknown etiology, which we hereafter refer to as pseudo-obstruction (Table 1) . Renal failure was responsible for most of the other premature deaths (Table 1) . Mortality was substantial after 6 months of age as well. Transgenic mice surviving beyond one year developed progressive renal disease and/or diverse histological types of tumors in multiple sites (Otsuka et al, 1998; Sakata et al, 1996; Takayama et al, 1997a Takayama et al, , 1997b . Wild-type FVB/N animals demonstrated neither intestinal nor renal disease.
HGF/SF transgenic mice also frequently exhibited rectal prolapse ( Fig. 2A) . A reddened anus was noticeable in many of the transgenic mice as early as 3 weeks of age, and sometimes blood was found on the prolapsed rectum. In severe adult cases, the whole rectum was prolapsed (Fig. 2B ). Anal glands in transgenic mice were often hyperplastic and/or cystic, perhaps contributing to this phenotype.
Histological Analysis of the Digestive Tract in HGF/SF Transgenic Mice
Microscopically, the stomach and small intestine appeared normal in HGF/SF transgenic mice, irrespective of the presence of the distension phenotype. However, vertical sections of the bowel frequently illustrated a pronounced thickening of the rectal wall, Analysis of transgenic hepatocyte growth factor/scatter factor (HGF/SF), native c-met, c-kit, and interleukin-2 (IL-2) transcripts in transgenic mouse colons by Northern blot hybridization. A, HGF/SF transgene expression in distal colons from 4-to 8-week-old MH19 and MH37 transgenic mice with (ϩ) or without (Ϫ) the addition of 25 mM zinc sulfate in the drinking water. B, Endogenous c-met, c-kit, and IL-2 expression in distal colons, including rectums, from 12-week-old control (Ϫ) and MH19 transgenic (ϩ) female mice. Note significantly reduced expression of IL-2 in transgenic distal colon. Filters were rehybridized with a glyceraldehyde-3-phosphate dehydrogenase (GAPDH) probe to assess RNA loading and transfer variation.
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especially at the anorectal junction (Fig. 3 , A to D). The crypts were elongated and showed evidence of proliferation (data not shown). In severe cases there was distortion of the crypts, including branching and cystic dilation (Fig. 3D) . Frequently, crypt abscesses (crypts containing a neutrophilic infiltrate) were identified ( Fig.  3E) . A mixed inflammatory cell infiltrate, consisting of lymphocytes, plasma cells, and neutrophilic granulocytes was moderately present in the lamina propria. Mucosal ulcerations were occasionally observed at the very end of the rectum (Fig. 3F ). This ulcerative proctitis, which developed with high penetrance, appeared to arise by a mechanism independent of the aforementioned intestinal pseudo-obstruction, which appeared sporadically and at sites distinct from the rectal thickening. In human patients, toxic megacolon associated with ulcerative colitis (UC) usually occurs with pancolitis and does not affect the small intestine (Sheth and LaMont, 1998) . Because intestinal inflammation in HGF/SF transgenic mice was limited to the rectum and dilation often extended over the small intestine, the intestinal pseudo-obstruction is not consistent with UC-related toxic megacolon.
Because HGF/SF transgenic mice were shown to exhibit abnormalities in neural crest development , and because a variety of spontaneous and gene-targeted mouse mutants and patients with Hirschprung's disease show intestinal obstruction associated with aberrant development of myenteric ganglia Hosoda et al, 1994; Schuchardt et al, 1994) , we evaluated the condition of such ganglia within the intestinal tracts of adult transgenic mice and their wild-type littermates. A D␤H-nlacZ transgene was bred into the HGF/SF transgenic colony to provide a useful marker of ganglion cell nuclei that could be visualized by histochemical staining of whole-mount preparations (Kapur et al, 1992) . However, no differences in the number or the distribution of enteric ganglion cells were identified between HGF/SF, D␤H-nlacZ double-transgenic mice and their D␤H-nlacZ single-transgenic littermates (Fig.  4A) . Similarly, whole-mount analysis of myenteric plexus architecture by acetylcholinesterase histochemical staining and light microscopic studies of transverse and longitudinal histological sections failed to reveal any differences between HGF/SF transgenic mice and their littermates (Fig. 4 , B to E). Included in the latter studies were asymptomatic transgenic animals as well as mice with external and internal gross anatomic signs of intestinal dysmotility (ie, abdominal distension and marked small intestinal distension). These data support the notion that HGF/SF transgenic mice develop an intestinal pseudo-obstruction, which was not due to aganglionosis or another resolvable malformation/degeneration of the enteric nervous system or to the intestinal smooth muscle, which was histologically indistinguishable from wild type. HGF/SF, hepatocyte growth factor/scatter factor. a Total number of analyzable transgenic mice from lines MH19 or MH37 exhibiting premature death, defined here as mice dying at Յ6 months of age. b Number of transgenic mice that died of intestinal pseudo-obstruction relative to total number of premature deaths; this lesion occurred most frequently in mice between 8 and 15 weeks of age.
c Number of transgenic mice that died of renal failure relative to total number of premature deaths. d Number of pregnant transgenic mice that died relative to total number of pregnant animals. The 10 mice in this study, combined from lines MH19 and MH37, died during or shortly after lactation of either obstruction (six) or renal failure (four). The increased incidence of premature death in pregnant females may be related to the impact of hormonal changes on the transgenic abdomen. 
Expression of Interleukin-2 and c-kit in the Large Intestine of HGF/SF Transgenic Mice
Because overt anatomical changes in the HGF/SF transgenic intestine were lacking, we speculated that the observed pseudo-obstruction was due to functional dysmotility. Based on reports that the receptor tyrosine kinase encoded by the c-kit proto-oncogene is required for development of the interstitial cells of Cajal (ICC), which have been implicated as part of the intestinal pacemaker system (Hulzinga et al, 1995; Histological analysis of inflammatory bowel disease (IBD) in the terminal colon and rectum of HGF/SF transgenic mice. A low-power view of vertical section of the terminal colon and rectum in a 8-week-old MH19 transgenic female mouse (B) and a control sibling (A). Note the thickened wall in the transgenic rectum (B). Arrows indicate anal canals. C and D, A high-power view of anorectal junctions of the same animals as in (A) and (B), respectively. The rectal wall is markedly thickened, and the crypts are elongated and distorted in the transgenic mouse (D). E, Crypt abscess represents a neutrophic infiltrate inside the lumen of crypts (arrow). F, Mucosal ulceration accompanied by mixed inflammatory cell infiltrate in the lamina propria (arrows). A and C, Control FVB/N mouse. B, D, E, and F, MH19 HGF/SF transgenic mouse. Original magnifications: A and B, ϫ10; C and D, ϫ40; E, ϫ400; F, ϫ200.
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Figure 4.
Lack of neuromuscular pathology in intestinal tracts of HGF/SF transgenic mice. A, X-gal-stained terminal colons of a HGF/SF, D␤H-nlacZ double-transgenic mouse (top), and its D␤H-nlacZ single-transgenic littermate (bottom) show similar uniform distributions of ganglion cell nuclei. B and C, Acetylcholinesterase-stained whole-mount preparations of mid-large intestine from a HGF/SF transgenic mouse (C) and its littermate (B) illustrate the normal two-dimensional architecture of the myenteric plexus that was associated with both genotypes. D and E, Photomicrographs of hematoxylin-and-eosin stained longitudinal sections of mid-large intestine from a symptomatic HGF/SF transgenic mouse (E) and its littermate (D) show nearly identical features. The only differences between the two are attributable to differences in tissue shrinkage, partially related to segment distension at the time of fixation. Scale bars: A, 800 m; B and C, 100 m; D and E, 50 m.
Intestinal Dysfunction in HGF/SF Transgenic Mice
Laboratory Investigation • March 2001 • Volume 81 • Number 3 Maeda et al, 1992; Torihashi et al, 1995; Ward et al, 1998; Yamataka et al, 1998) , we examined c-kit expression in the distal colon of HGF/SF transgenic mice by Northern blot analysis. The level of c-kit expression in the transgenic colon was essentially equal to that in wild-type mice (Fig. 1B) , indicating that intestinal pseudo-obstruction was likely caused by a mechanism other than altered c-kit expression or significant loss of ICC.
It has been shown that gene-targeted disruption of the cytokine genes, interleukin-2 (IL-2) and interleukin-10 (IL-10), produced mice that developed intestinal lesions similar to those of human inflammatory bowel disease (IBD) (Kühn et al, 1993; Sadlack et al, 1993) . We therefore examined expression of IL-2 and IL-10 RNA transcripts in the distal colon, including the rectum, where IBD-like phenotypic changes were observed in the absence of pseudo-obstruction. There was no significant difference in IL-10 expression between the transgenic and wildtype colon (data not shown). In contrast, the IL-2 expression level was markedly reduced in the colons of HGF/SF transgenic mice, raising the possibility that insufficient amounts of IL-2 may contribute to the induction of chronic rectal inflammation in the HGF/SF transgenic mouse (Fig. 1B) .
Discussion
Growth factors and their receptors play important roles in cell proliferation, migration, wound repair, and ulcer healing. Under normal conditions, cell populations within the gastrointestinal tract are maintained in a dynamic state because cell loss through exfoliation of surface cells is balanced by a continuous cell renewal. The balance between cell loss and renewal in the digestive tract, often upset in the pathologic state, appears to be tightly regulated by several growth factors including those of the epidermal growth factor (EGF) family, the transforming growth factor beta (TGF-␤) family, the insulin-like growth factor (IGF) family, and the fibroblast growth factor (FGF) family (Jones et al, 1999) . The role of HGF/SF in digestive tract disorders has not been as well characterized. Previous studies have shown that expression of HGF/SF and c-MET mRNA among UC and control patients was comparable (Chowdhury et al, 1996) . In contrast, serum HGF/SF levels in patients with IBD were higher than those in healthy individuals (Matsuno et al, 1997) . In this study we use a transgenic mouse model to show that inappropriate expression of HGF/SF can induce both sporadic intestinal pseudoobstruction and a rectal IBD. This animal model has the potential to elucidate mechanisms regulating intestinal motility and mucosal protection in patients.
Severe intestinal dysmotility can be caused by congenital enteric aganglionosis in humans with Hirschsprung's disease and in a variety of spontaneous and gene-targeted mouse mutants, including RET, GDNF, endothelin-3, endothelin-B receptor, and SOX10 null mutations Hosoda et al, 1994; Moore et al, 1996; Pichel et al, 1996; Pingault et al, 1998; Sanchez et al, 1996; Schuchardt et al, 1994) . As enteric ganglia in the HGF/SF transgenic intestine are intact, the pathogenesis is different from that operating in Hirschsprung's disease. Instead, HGF/SF transgenic mice represent a new model of intestinal pseudo-obstruction, a rare disorder in which impaired intestinal motility leads to Hirschsprung's disease-like symptoms, but ganglion cells are present throughout the entire alimentary tract. The origins of pseudoobstruction are heterogeneous and often obscure (Krishnamurthy and Schuffler, 1987) . Some forms are characterized by degenerative changes in enteric neurons or smooth muscle that were not observed in HGF/SF transgenic mice. Another subset of patients and animal models have subtle changes in enteric ganglion cell number or other cell types that could not be excluded by the methods used in our study. This includes patients with chronic obstructive symptoms and reduced numbers of ICC, modified smooth muscle cells that function as a "pacemaker" system for the intestinal tract (Faussone-Pellegrini et al, 1999a , 1999b Yamataka et al, 1998) . Although it is unclear whether changes evident in the ICC of the latter group are primary or secondary to underlying obstructive symptoms, mutations that impair expression of c-kit receptor by ICC lead to loss of these cells and intestinal dysmotility in mice. Although impaired ICC function has not been excluded in HGF/SF transgenic mice, we found no difference in the levels of c-kit mRNA in transgenic colon compared to wild type. At present, like many pseudo-obstruction patient/animal models, HGF/SF transgenic mice lack any recognized neuromuscular pathology and are presumed to result from physiological defects in the enteric nervous system or smooth muscle. However, given that the HGF/SF receptor, c-Met, is expressed in gastrointestinal epithelium, it remains a possibility that impaired motility in these transgenic animals is due to altered epithelial function resulting in increased fecal viscosity.
UC is a chronic, presumably noninfectious, inflammation limited to the large intestine. In approximately one quarter of UC patients the disease is limited to the rectum (proctitis). The major working hypothesis concerning the pathogenesis of UC is that the disease is due to an abnormal and uncontrolled immune response to one or more normally occurring gut constituents. Previous studies have shown that genetargeted disruption of either of the genes encoding the cytokines IL-2 and IL-10, the T cell receptor genes, or the mdr1a gene creates mice that develop UC-like intestinal lesions similar to those of human IBD (Kühn et al, 1993; Mombaerts et al, 1993; Panwala et al, 1998; Sadlack et al, 1993) . It is notable that IL-2 expression is decreased in the colon of HGF/SF transgenic mice exhibiting IBD without pseudoobstruction. Growth factors regulate a wide spectrum of processes which include protection of the intestinal mucosa and activation and regulation of the intestinal immune system. It has been speculated that human IBD is a disease of multigenic etiology (Beck and Podolsky, 1999 ). An IL-2 deficiency caused by forced HGF/SF expression in the transgenic colon may induce inflammatory responses leading to IBD. In fact, Takayama et al HGF/SF transgenic mice frequently develop anorectal prolapse, found in both IL-2-deficient and T cell receptor mutant mice that develop UC-like IBD. It remains to be determined whether the observed rectal pathology results directly from HGF/SF overexpression or from the complex deregulation of the immune system caused by the associated IL-2 deficiency. It would be illuninating to cross IL-2 transgenic mice with HGF/SF transgenic mice to determine if IL-2 overexpression can rescue the phenotypes seen in the HGF/SF transgenic colon.
In conclusion, we have determined that inappropriate expression of HGF/SF in the digestive tract of mice can induce intestinal pseudo-obstruction of unknown etiology and ulcerative proctitis associated with diminished IL-2 expression. These findings suggest a possible role for HGF/SF, not only in gastrointestinal motility, but also in epithelial repair and mucosal protection. HGF/SF may contribute to a fraction of IBD by influencing the local production of cytokines that constitute the intestinal immune system. Although HGF/SF has been applied therapeutically in the treatment of patients with, for example, peripheral arterial disease or liver cirrhosis (Ueki et al, 1999) , the correlation of chronic elevated HGF/SF exposure with a high incidence of premature death in transgenic mice associated with both gastrointestinal disease, shown here, as well as renal failure, reported earlier (Takayama et al, 1997a) , demonstrates the potential liability in the use of HGF/SF in a clinical context. The HGF/SF transgenic mouse model may provide fresh insights into pathogenic mechanisms associated with the gastrointestinal disease process and facilitate the exploration of prospects for prevention and therapeutic intervention.
Materials and Methods
Animals
Transgenic mice harboring a mouse HGF/SF cDNA under the control of the mouse MT gene promoter and 5'/3' flanking sequences (Palmiter et al, 1993) were generated on a FVB/N genetic background as previously described . Where indicated, the MT transgene promoter was maximally induced by maintaining mice on drinking water containing 25 mM zinc sulfate; however, exposure to zinc was not required for the development of gastrointestinal phenotypes. Two independently derived lines of HGF/SF transgenic mice, MH19 and MH37, were used in these studies. The criteria for intestinal pseudoobstruction was the presence of symptoms and signs of intestinal obstruction with no mechanical obstruction or chronic constipation, excluding Hirschsprung's disease (Faure et al, 1999) . Animals used in this specific study were kept in a facility devoid of all pathogens except the spiral-shaped bacterium Helicobacter. Although intestinal microflora can influence the pathogenesis of intestinal inflammation and prolapse, we have observed the same spectrum of gastrointestinal phenotypes in other Helicobacter-free HGF/SF transgenic animals. All animal studies were performed in accordance with the guidelines for animal care and use established by the National Institutes of Health (NIH). zidine and 0.8% NiCl 2 . H 2 O 2 (0.03%) was added to the reaction, and the sample was monitored for color transformation (1-5 minutes).
